Meet Tiffany Traina: Breast Medical Oncologist at MSK

Dr. Tiffany Traina cares for people with breast cancer at MSK, specializing in triple-negative breast cancer, targeted therapy, and breast cancer clinical trials.
Video Details
 Memorial Sloan Kettering medical oncologist Tiffany Traina

Tiffany A. Traina, MD, FASCO

Breast Medical Oncologist

Areas of Expertise

Conditions I Treat

  • Breast cancers and conditions
  • Triple-negative breast cancer (TNBC)

My Specialties

  • Targeted therapy
  • Clinical trials
Dr. Traina's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified medical oncologist whose clinical practice is dedicated exclusively to the care of patients with all stages of breast cancer. I am part of a large, multidisciplinary team of devoted specialists who share my goal of providing exceptional care to patients fighting breast cancer. Through my research activities, I work to develop new therapeutic options for the treatment of breast cancer and to ultimately eradicate this disease.

My research has centered on the use of novel, targeted therapies for the treatment of triple negative breast cancer (TNBC). Currently, I am the lead investigator for a multicenter trial studying the use of androgen receptor inhibition for patients with advanced TNBC. I have investigated numerous other targets for treatment of this subtype of breast cancer, including src and PARP, and have collaborated to develop biologic predictors of response to conventional therapies such as platinum. I have also had a special interest in optimizing drug delivery schedules to minimize side effects of treatment while maximizing its benefits.

I have received grant support for my work from the Breast Cancer Alliance and the Translational Breast Cancer Research Consortium (TBCRC) — a nationwide panel of centers of excellence in breast cancer medicine — where I also serve on the Triple Negative Breast Cancer working group panel. I have lectured internationally and presented our research findings at forums including the annual San Antonio Breast Cancer Symposium and the annual meeting of the American Society of Clinical Oncology (ASCO). I am a member of the New York Metropolitan Breast Cancer Group and serve on the editorial board of the European Journal of Clinical & Medical Oncology. Additionally, I am an ad hoc reviewer for several clinical journals and have published in scientific journals including the Journal of Clinical Oncology and Clinical Cancer Research.

I am committed to providing compassionate care to my patients as they undergo treatment for their breast cancer.

What I Do at MSK

I'm a breast medical oncologist, which is a cancer doctor who specializes in breast cancer.

  • Vice Chair of Outpatient Operations, Department of Medicine
  • Section Head, Triple Negative Breast Cancer Clinical Research Program
Areas of Expertise

Conditions I Treat

  • Breast cancers and conditions
  • Triple-negative breast cancer (TNBC)

My Specialties

  • Targeted therapy
  • Clinical trials
Education & Honors

Education

  • MD, Weill Cornell Medical College

Residencies

  • Internal Medicine - New York Presbyterian/Weill Cornell Medical Center
  • Internal Medicine - Memorial Sloan Kettering Cancer Center

Fellowships

  • Internal Medicine - Memorial Sloan Kettering Cancer Center
  • Medical Oncology/Hematology - Memorial Sloan Kettering Cancer Center
  • Internal Medicine - New York Presbyterian/Weill Cornell Medical Center

Board Certifications

  • Internal Medicine
  • Medical Oncology

Awards and Honors

  • Castle Connolly: America’s Top Doctor (2025)
  • Fellow, American Society of Clinical Oncology (2023)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9064— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY
Evelyn H. Lauder Breast Center
300 East 66th Street Floors 1 - 4 New York NY 10065
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. I work closely with nurse practitioner Nicole M. DeVine. We combine our expertise to provide comprehensive care to our patients at every step of their cancer journey.

See all Leadership doctors

See all Breast Medicine Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Traina’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Tiffany A. Traina discloses the following relationships and financial interests:

  • Aktis Oncology, Inc.
    Professional Services and Activities
  • AstraZeneca
    Professional Services and Activities
  • BioNTech
    Professional Services and Activities
  • Curio Science LLC
    Professional Services and Activities
  • Daiichi Sankyo
    Professional Services and Activities
  • Ellipses Pharma
    Professional Services and Activities
  • Exact Sciences Corporation
    Professional Services and Activities
  • Genentech
    Professional Services and Activities
  • Gilead Sciences, Inc.
    Professional Services and Activities
  • Medscape
    Professional Services and Activities
  • Pfizer, Inc.
    Professional Services and Activities
  • Physicians' Education Resource
    Professional Services and Activities
  • Research to Practice
    Professional Services and Activities
  • Roche
    Professional Services and Activities
  • Veracyte, Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures

Related topics: